Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Hydrophobic low-molecular-weight substances" is not the name of a specific molecule or therapeutic target. Instead, it refers to a broad class of nonpolar molecules that do not interact favorably with water due to their lack of electrical charge. These molecules are characterized by their tendency to aggregate together in aqueous environments—a phenomenon known as the hydrophobic effect—and include alkanes, oils, fats, cholesterol, certain vitamins (A, D, K), and many other organic compounds[1][2][3][6]. In biology and chemistry contexts, hydrophobic interactions are crucial for the proper folding of proteins and the formation/stability of cellular membranes composed largely of phospholipids. These interactions also underlie many industrial applications such as oil-water separation and waterproofing materials[1][2]. The term does not refer to any single receptor or enzyme but rather describes a general property shared by many chemically diverse small molecules. As such, - It is not considered a therapeutic target like receptors or enzymes. - There is no canonical abbreviation. - There are no specific drugs that "target" this group as an entity; rather individual hydrophobic small molecules may be drug targets themselves if they have defined biological activity. Because "Hydrophobic low-molecular-weight substances" does not correspond to any recognized molecular target or receptor class—and instead describes a physicochemical property—the entry should be flagged as incorrect for use as a structured drug discovery/target database entry[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydrophobic low-molecular-weight substances.